Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation

Journal of Cellular Biochemistry

Volumn 114, Issue 11, 2013, Pages 2612-2623

  Saini, Uksha ^a   Gumina, Richard J ^a   Wolfe, Brian ^a   Kuppusamy, M Lakshmi ^a   Kuppusamy, Periannan ^a   Boudoulas, Konstantinos Dean ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Caspase Inhibitor; Hyperoxia; Hypoxia; Mesenchymal Stem Cells; Preconditioning

Indexed keywords

BROXURIDINE; CASPASE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 9; CASPASE INHIBITOR; I KAPPA B; LIPOCORTIN 5; MARKER; PROTEIN BCL 2;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HEART INFARCTION; HYPEROXIA; HYPOXIA; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

APOPTOSIS; CASPASE INHIBITOR; HYPEROXIA; HYPOXIA; MESENCHYMAL STEM CELLS; PRECONDITIONING;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; CASPASE 1; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 9; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; MALE; MESENCHYMAL STROMAL CELLS; RATS;

EID: 84884220766     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24609     Document Type: Article

References (35)

1. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B,. 2007. Adult bone marrow-derived cells for cardiac repair a systematic review and meta-analysis. Arch Intern Med 167: 989-997.
2. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM,. 2006. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355: 1222-1232.
3. Bel A, Messas E, Agbulut O, Richard P, Samuel JL, Bruneval P, Hagège AA, Menasché P,. 2003. Transplantation of autologous fresh bone marrow into infarcted myocardium: A word of caution. Circulation 108 (Suppl. I) II-247-II-252.
4. Boudoulas KD, Hatzopoulos AK,. 2009. Cardiac repair and regeneration: The Rubik's cube of cell therapy for heart disease. Dis Model Mech 2: 344-358.
5. Brazil DP, Hemmings BA,. 2001. Ten years of protein kinase B signaling: A hard Akt to follow. Trends Biochem Sci 26: 657-664.
6. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP,. 2004. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94: 92-95.
7. Choi H, Kim SH, Chun YS, Cho YS, Park JW, Kim MS,. 2006. In vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2. Exp Biol Med 231: 463-472.
8. Cory S, Adams JM,. 2002. The Bcl-2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656.
9. Filip S, Mokry J, Horacek J, English D,. 2008. Stem cells and the phenomena of plasticity and diversity: A limiting property of carcinogenesis. Stem Cells Dev 17: 1031-1038.
10. Foadoddini M, Esmailidehaj M, Mehrani H, Sadraei SH, Golmanesh L, Wahhabaghai H, Valen G, Khoshbaten A,. 2011. Pretreatment with hyperoxia reduces in vivo infarct size and cell death by apoptosis with an early and delayed phase of protection. Eur J Cardiothorac Surg 39: 233-240.
11. Franek WR, Horowitz S, Stansberry L, Kazzaz JA, Koo HC, Li Y, Arita Y, Davis JM, Mantell AS, Scott W, Mantell LL,. 2001. Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J Biol Chem 276: 569-575.
12. Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ,. 2010. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 21: 1513-1526.
13. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, Ganser A, Knapp WH, Drexler H,. 2005. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111: 2198-2202.
14. Itoh G, Tamura J, Suzuki M, Ikeda H, Koike M, Nomura M, Jie T, Ito K,. 1995. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 146: 1325-1331.
15. Kang H, Lee H, Na S, Chang S, Park K, Kim H, Kim S, Chang H, Lee W, Kang W, Koo B, Kim Y, Lee D, Sohn D, Han K, Oh B, Park Y, Kim H,. 2006. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: The MAGIC Cell-3-DES randomized, controlled trial. Circulation 114 (1 Suppl.): I145-I151.
16. Khan M, Meduru S, Mohan IK, Kuppusamy ML, Wisel S, Kulkarni A, Rivera BK, Hamlin HL, Kuppusamy P,. 2009. Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J Mol Cell Cardiol 47: 275-287.
17. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA, Hardwick JM,. 1999. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 274: 21155-22161.
18. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lützow K, Lendlein A, Stamm C, Li RK, Steinhoff G,. 2007. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25: 2118-2127.
19. Meluzin J, Mayer J, Groch J, Janousek S, Hornácek I, Hlinomaz O, Kala P, Panovský R, Prásek J, Kamínek M, Stanícek J, Klabusay M, Korístek Z, Navrátil M, Dusek L, Vinklá rková J,. 2006. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function. Am Heart J 152: 975.e9-975.e15.
20. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagège AA,. 2008. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 117: 1189-1200.
21. Mersmann J, Zacharowski PA, Schmitz I, Zacharowski K,. 2008. Caspase inhibitor Z-VAD-FMK reduces infarct size after myocardial ischaemia and reperfusion in rats but not in mice. Resuscitation 79: 468-474.
22. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H,. 2006. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113: 1287-1294.
23. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, Ishino K, Ishida H, Shimizu T, Kangawa K, Sano S, Okano T, Kitamura S, Mori H,. 2006. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459-465.
24. Robey TE, Saiget MK, Reinecke H, Murry CE,. 2008. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45: 567-581.
25. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 125: 188-197.
26. Rokudai S, Fujita N, Hashimoto Y, Tsuruo T,. 2000. Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis. J Cell Physiol 182: 290-296.
27. Schoen FJ, Mitchell RN,. 2005. The heart. In:, Kumar V, Abbas AK, Fausto N, editors. Robbins and Cotran: Pathologic basis of disease, 7th edition. Philadelphia: Elsevier Saunders. pp 555-618.
28. Strauer BE, Steinhoff G,. 2011. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: From the methodological origin to clinical practice. J Am Coll Cardiol 58: 1095-1104.
29. Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, Yacoub MH,. 2004. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 18: 1153-1155.
30. Tähepõld P, Vaage J, Starkopf J, Valen G,. 2003. Hyperoxia elicits myocardial protection through a nuclear factor kappaB-dependent mechanism in the rat heart. J Thorac Cardiovasc Surg 1259: 650-660.
31. Thornberry NA, Lazebnik Y,. 1998. Caspases: Enemies within. Science 281: 1312-1316.
32. Valen G, Yan ZQ, Hansson GK,. 2001. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38: 307-314.
33. Wang CY, Mayo MW, Baldwin AS, Jr., 1996. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274: 784-787.
34. Yaoita H, Ogawa K, Maehara K, Maruyama Y,. 1998. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97: 276-281.
35. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE,. 2001. Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921.